Phase II trial of dolastatin-10, a novel anti-tubulin agent, in metastatic soft tissue sarcomas

Author: von Mehren M.  

Publisher: Informa Healthcare

ISSN: 1369-1643

Source: Sarcoma, Vol.8, Iss.4, 2004-12, pp. : 107-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content